Skip to content

Deep Learning Protocols for Predicting Drug Mechanism of Action and Drug-Target Interactions.

Sep 2026 · Methods in molecular biology · Vol 3074, pp. 39-51 · 0 citations
Medicine

TL;DR

Two deep learning-based computational protocols designed to address drug mechanisms of action and predicting drug-target interactions are presented, offering scalable, cost-effective tools for accelerating therapeutic development by bridging chemical structure, molecular interactions, and systems-level biological responses.

View source

Similar papers

Review Sep 2026

Significant Advances in Research on Drug-Drug Interactions in the Past Five Years

This review systematically analyzes key challenges in DDI prediction: balancing model performance with interpretability, integrating heterogeneous features, ensuring sample set reliability, and optimizing algorithmic architectures, and outlines promising directions for future innovation.

Yun Zuo, Jia-Yi Ji, Yuwen Li et al. · 0 citations
Review Sep 2026

Precision Drug Discovery in the Era of Artificial Intelligence: A Critical Review.

A paradigm shift toward autonomous scientific agents capable of causal reasoning and end-to-end experimental guidance is highlighted, and persistent challenges are discussed, including data bias, limited interpretability, and in silico-to-wet lab translation.

Meng Liu, Jia-Cheng Xiong, Ming-Yue Zheng · 1 citation
Open access Sep 2026

Deciphering Mechanistic Signatures in Drug-Drug Interactions with Dual Topology Graphs

Drug-drug interactions (DDIs) represent a critical challenge in drug development and clinical practice, as they can lead to severe adverse effects, including toxicity and reduced therapeutic efficacy. Deep learning methods have shown promise in large-scale, rapid DDI prediction; however, current approaches suffer from...

Wen-Jian Ma, Xiang-Peng Bi, Hua-Sen Jiang et al. · 0 citations
Review Aug 2026

Advancing cancer drug discovery through the integration of machine learning and high-throughput screening.

This review highlights the synergy between AI and HTS, emphasizing DL techniques such as convolutional neural networks for bioactivity prediction, recurrent neural networks for de novo design, and reinforcement learning for property optimization.

Kamil Herbetko, Katarzyna Herbetko, Magdalena Mikołajek et al. · 1 citation
Open access Sep 2026

A Machine Learning Approach for Predicting Synergism of Mixtures of Compounds in Treating Cancers

Combination therapy is a common strategy in cancer treatment to improve efficacy, minimize side effects, and overcome drug resistance. However, the vast number of possible drug pairings makes experimental screening both time-consuming and costly. Drug interactions can result in synergy and antagonism, emphasizing the n...

Azar Shamloo, Jack Tuszynski, Yun Tam et al. · 0 citations
Open access Sep 2026

Comprehensive Evaluation of Protein Language Model Embeddings for Drug–Target Affinity Prediction

Results indicate simple architectural modifications to traditional convolution methods may be sufficient to bridge the gap to large pre-trained PLMs, and an architectural modification of the baseline convolution method designed to improve protein representation learning is evaluated.

Matija Marijan, Ivan Tanasijević · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.